The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19

Jampol, Lee M; Moy, Claudia S; Murray, Timothy G; Reynolds, Sandra M; Albert, Daniel M; Schachat, Andrew P; Diddie, Kenneth R; Engstrom, Robert E; Finger, Paul T; Hovland, Kenneth R; Joffe, Leonard; Olsen, Karl R; Wells, Craig G; COMS Follow-up of Plaqued Eyes Working Group,

« Previous Next »Ophthalmology
Volume 109, Issue 12 , Pages 2197-2206, December 2002

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma:☆

IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19

Lee M Jampol, MD
- Department of Ophthalmology, Northwestern University Medical School, Chicago, Illinois, USA
Claudia S Moy, PhD
- Wilmer Ophthalmological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
- Current affiliation: National Institutes of Health/NINDS, Bethesda, Maryland, USA
- Correspondence to Claudia S. Moy, PhD, COMS Coordinating Center, NIH/NINDS, Neuroscience Center, Room 2214, 6001 Executive Boulevard, MSC 9520, Bethesda, MD 20892-9520, USA.
Timothy G Murray, MD
- Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, USA
Sandra M Reynolds, MA
- Wilmer Ophthalmological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Daniel M Albert, MD
- Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, USA
Andrew P Schachat, MD
- Wilmer Ophthalmological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Kenneth R Diddie, MD
- Doheny Eye Institute, University of Southern California School of Medicine, Los Angeles, California, USA
Robert E Engstrom Jr., MD
- Jules Stein Eye Institute, University of California Los Angeles Medical Center, Los Angeles, California, USA
Paul T Finger, MD
- New York Eye Cancer Center, New York, New York, USA
Kenneth R Hovland, MD
- Porter Adventist Hospital, Denver, Colorado, USA
Leonard Joffe, MD
- Retina Associates Southwest, Tucson, Arizona, USA
Karl R Olsen, MD
- Retina-Vitreous Consultants, Pittsburgh, Pennsylvania, USA
Craig G Wells, MD
- Department of Ophthalmology, University of Washington, Seattle, Washington, USA
COMS Follow-up of Plaqued Eyes Working Group

Received 7 September 2001; accepted 20 May 2002.

To access this article, please choose from the options below

☆ Manuscript no. 210753.A complete listing of the COMS Group as of September 30, 2000, may be found in Arch Ophthalmol 2001;119:969–82.Supported by the National Eye Institute and National Cancer Institute, National Institutes of Health, Bethesda, Maryland (cooperative agreement nos.: EY 06253, EY 06257, EY 06258, EY 06260, EY 06264, EY 06265, EY 06266, EY 06269, EY 06270, EY 06274, EY 06275, EY 06276, EY 06279, EY 06280, EY 06282, EY 06283, EY 06284, EY 06287, EY 06288, EY 06289, EY 06291, EY 06839, EY 06843, EY 06844, EY 06848, EY 06858, and EY 06899).The authors have no proprietary interest in any device reported in this paper.Reprint requests to COMS Coordinating Center, Wilmer Clinical Trials and Biometry, 550 North Broadway, Ninth Floor, Baltimore, MD 21205.

PII: S0161-6420(02)01277-0

Refers to erratum:

Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration
Ophthalmology September 2004 (Vol. 111, Issue 9, Page 1640)
- Full Text
- PDF (28 KB)
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19
Ophthalmology August 2004 (Vol. 111, Issue 8, Page 1514)
- Full Text
- PDF (28 KB)